Outcome of Board Meeting of Advance Agrolife Limited held on Friday May 08, 2026

Revenue Growth 20pctPat Growth 25pctNegative Operating CashflowResults View source PDF Explain this filing

ADVANCE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-0.3%Reaction day

₹112.32

prior close

₹116.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.4%+1.1% vs market

Pesticides & Agrochemicals peers, median of 28sector-1.6%+1.3% vs sector

On the reaction day the stock moved 1.1 pts more than Nifty Microcap 250 and 1.3 pts more than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-2.5

10m

-1.6

15m

-1.5

30m

-3.5

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-0.3-1.4+1.1-1.6+1.3

Next day

-5.1-4.5-0.6-3.5-1.6

-7.4-3.8-3.6-3.6-3.8

-7.5-3.6-4.0-3.5-4.0

-8.7-3.9-4.8-4.3-4.4

-10.3-5.2-5.1-5.9-4.4

-10.4-4.2-6.2-5.4-5.0

15d

-9.2-1.5-7.7-7.6-1.6

-14.8-3.1-11.7-8.2-6.6

+1.2+6.4-5.2-6.0+7.2

+8.8+8.3+0.5-4.2+13.0

UpDownMarket · Nifty Microcap 250Sector · Pesticides & Agrochemicals peers, median of 28Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Advance Agrolife Limited's Board approved audited standalone financial results for FY2026. Revenue from operations grew 27% to ₹637.8 million from ₹502.3 million in FY2025. Profit after tax rose 38% to ₹352.8 million from ₹256.4 million. EPS increased to ₹6.50 from ₹5.70. The statutory auditor issued an unmodified opinion. The Board also reappointed PSAG & Associates as Internal Auditor and M Goyal & Co as Cost Auditor for FY2026-27. However, operating cash flow turned significantly negative at -₹700.35 million for FY2026 versus +₹57.13 million in the prior year, driven by large inventory buildup (up from ₹876 million to ₹2,052 million) and rising trade receivables. The company raised ₹1,738 million in equity capital (₹192.86 million capital + ₹1,545.20 million premium) during the year.

Likely market impact

Strong topline and bottom-line growth with clean audit is positive. However, the sharp negative operating cash flow despite higher profitability raises concerns about working capital management and liquidity, which shareholders should monitor closely.